Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Individual Patient Response from the Pooled DERMIS-1 and DERMIS-2 Phase 3 Trials. J of Skin. 2024;8(1):s310. doi:10.25251/skin.8.supp.310